Happiest Diagnostics, a unit of Happiest Health, has received accreditation from the National Accreditation Board for Testing and Calibration Laboratories (NABL), marking a significant milestone in its growth journey. Achieved within just two years of inception, the accreditation reflects strong governance, disciplined execution, and the early maturity of robust quality systems.
Quality Built In from Day One
From the outset, Happiest Diagnostics designed, commissioned, and operated its laboratories in strict alignment with NABL guidelines. As a result, the organisation enabled a smooth, structured, and efficient accreditation process. Throughout its diagnostic services, the team places unwavering emphasis on accuracy, reproducibility, and traceability, while maintaining an uncompromised focus on clinical quality.
Leadership Vision for a Future-Ready Diagnostics Platform
As per the press release, sharing the broader vision, Mr. Ashok Soota, Chairman & Chief Strategy Officer, Happiest Health, said, “Our vision is to build a future-ready diagnostics platform governed by strong quality systems, capable of handling complex biological data, and scalable for advanced testing needs. This milestone strengthens our foundation to systematically expand into molecular, genomic, and preventive diagnostics, supporting how medicine will increasingly be practiced over the next decade.”
Accelerating Expansion into Advanced Diagnostics
NABL accreditation provides a strong foundation for expanding the company’s accredited test menu and supports its progressive move into advanced diagnostics, including molecular and genomic testing. Moreover, the diagnostic roadmap aligns closely with preventive, predictive, and personalised healthcare needs, with a clear focus on introducing rare and clinically significant tests that remain under-available in routine diagnostic settings.
Enhancing Trust Through the Atithi Experience
Commenting on the milestone, Mr. Davis Karedan, Co-Chairman & COO, Happiest Health, said, “For us, NABL accreditation is not just a regulatory achievement—it directly enhances the Atithi experience. It assures patients and clinicians that every report is built on rigor, consistency, and trust. As diagnostics becomes central to clinical decision-making, our focus remains on delivering accuracy, transparency, and dependability at every touchpoint—from sample collection to interpretation. This accreditation reinforces our commitment to clinically reliable and patient-centric diagnostics.”
Building a Next-Generation Reference Laboratory
While the current NABL accreditation marks a major step forward, Happiest Diagnostics is simultaneously developing a large reference laboratory. This facility will significantly expand its accredited test portfolio—nearly tripling the current offerings—while enabling advanced and specialised testing capabilities. Envisioned as a central hub for quality, standardisation, and complex diagnostics, the reference lab will support the organisation’s next phase of growth across molecular, genomic, and data-intensive testing.
Introducing Data-Intensive Preventive Diagnostics
As part of its advanced diagnostics portfolio, Happiest Diagnostics has introduced Gut Microbiome Testing. By leveraging high-throughput sequencing and advanced bioinformatics, the test analyses more than 5 GB of microbial genomic data per sample. Consequently, it delivers clinically relevant insights into digestive health, metabolic balance, immune modulation, and overall wellness, reinforcing the organisation’s focus on preventive, predictive, and personalised care.
Clinical Leadership on the Role of Diagnostics
Highlighting the clinical significance, Dr. Bikash Kumar Chaudhury, CEO & Senior Vice President, Happiest Diagnostics, said, “Diagnostics now plays a central role in clinical decision-making across prevention, diagnosis, and long-term care. NABL accreditation validates the strength of our quality and clinical frameworks, reinforcing confidence in the accuracy and reliability of our reports. This milestone enables the expansion of advanced and data-intensive diagnostics while ensuring complex biological data is governed responsibly. Our focus remains on delivering clinically actionable insights that support early intervention and personalised, preventive healthcare.”
Investing in the Future of Trusted Diagnostics
Looking ahead, Happiest Diagnostics plans continued investments in automation, quality systems, and advanced diagnostics. With a long-term vision to build a future-ready, clinically rigorous, and nationally trusted diagnostic ecosystem, the organisation remains committed to setting new benchmarks in quality-driven healthcare diagnostics.